Patent classifications
A61K36/00
Method for extracting bioactive ingredient and bioactive ingredient obtained thereby
A method of extracting a bioactive ingredient, including the following steps: step 1) heating a pre-treated fresh cannabis raw material in a vacuum state; step 2) cooling an upper part of the raw material; step 3) collecting a liquid formed in step 2) and containing a bioactive substance; step 4) dispensing and storing the collected liquid containing the bioactive substance.
System, method and apparatus for cannabinoid tincture separation and solvent recovery
A system for processing cannabinoids and recovering solvent has a vessel for a mixture of cannabinoids and solvent. A pump forms a vacuum in the system to draw the mixture into a first heat exchanger to pre-heat the mixture. A falling film evaporator receives the mixture from the first heat exchanger, and boils the mixture to form a solvent vapor. The falling film evaporator collects the cannabinoids from the mixture as a crude oil. The first heat exchanger receives the solvent vapor. Heat is transferred to incoming mixture of the system, and cools and condenses the solvent vapor to form solvent condensate and vapor. A second heat exchanger receives and further cools the solvent condensate and vapor to form further condensed solvent and some solvent vapor. The pump receives the further condensed solvent and some solvent vapor and increases pressure to form solvent liquid and recovers solvent liquid for reuse.
VAPOR MEDICINE DISPENSING AND NANO-MIST LUNG CLEANSER SYSTEM WITH NASAL ADAPTER
A system, accompanying apparatuses and methods relating to an oral, nasal or propellant enhanced mist delivery, drug delivery and lung cleansing apparatuses and having for an object to provide a safe and harmless means for and method of delivering medication with heated, moist, flavored air; or by inhaling warm medication like methanol into the lungs in case of a respiratory ailment under direction of a physician. Additionally, all state of the art medicines are envisioned for delivery with the system.
Compositions comprising thymoquinone and omega-3 fatty acids
The present invention provides a composition comprising a synergistic combination of thymoquinone and one or more omega-3 fatty acids, wherein the molar ratio between said thymoquinone and said one or more omega-3 fatty acids is at least 1:7. The present invention also provides a method of using said composition to treat or prevent inflammatory conditions.
Composition for preventing or improving inflammation including extract of seed of new soybean cultivar SCEL-1
Provided are a composition for preventing or improving inflammation, the composition including an extract of a seed of soybean Glycine max (L.) Merrill cultivar SCEL-1, and a method of preventing occurrence of inflammation in a subject or improving inflammation in a subject, the method including injecting the composition to a subject.
Method for restoring male sex drive (libido)
The method for restoring male sex drive (libido) using a food supplement for restoring male sex drive (libido) relates to medicine, and more specifically to the pharmaceutical industry producing food supplements for restoring male sex drive (libido) and male sexual function which are based on natural ingredients. The method involves the use of nitric oxide (NO) in terms of L-arginine, pollen or beebread in terms of rutin, drone brood in terms of decenoic acids, a substance containing zinc in terms of zinc, a substance containing vitamin B6 in terms of vitamin B6, horny goat weed in terms of icariin, true or false ginseng root in terms of saponins, and leuzea or crowned saw-wort in terms of ecdysteroids, in various combinations.
Skin tightening lotion
Compositions for tightening the skin and reducing muscle pain, bruising, and swelling in skin and methods of forming such compositions.
Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
The invention relates to grass pollen extracts containing reduced amount of flavonoid glycosides in order to minimize the risks of genotoxicity of the grass pollen extracts. The invention also relates to a method of preparing grass pollen extracts containing reduced amount of flavonoid glycosides by ultrafiltration. Flavonoid glycosides are naturally present in grass pollen extracts and they have been identified as being responsible for the formation of flavonoid aglycones, which are genotoxic in vitro, under the influence of enzymes contained in the grass pollen extracts.
PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING
The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING
The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.